Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.22 USD | +2.12% | +4.47% | +38.24% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.24% | 2.87B | |
+16.71% | 121B | |
+13.20% | 107B | |
-5.64% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.42% | 15.31B | |
+2.03% | 14.08B | |
+24.37% | 11.74B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- PTC Therapeutics Shares Fall After Chief Executive Officer Exit Announcement